BioSpace News Archive

SciSparc Announces Israeli Ministry of Health Approval to Conduct its Clinical Trial in Autism Spectrum Disorder

SciSparc Ltd. today announced that it has received approval from the Israeli Ministry of Health to conduct the Company’s clinical trial for SCI-210 in patients suffering from autism spectrum disorder (“ASD”).

August 8, 2022
·
4 min read
Genetown

Research from Beacon Biosignals Presented at Alzheimer’s Association International Conference

Beacon Biosignals, a startup that applies AI to EEG to unlock precision medicine for neurological and psychiatric disorders, presented research at the Alzheimer’s Association International Conference, which took place July 31–Aug. 4, 2022, in San Diego.

August 8, 2022
·
4 min read
CUMBERLAND PHARMACEUTICALS REPORTS 2.4M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2021

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released its 2021 Sustainability Report detailing its activities regarding its involvement in environmental, social and governance matters.

August 8, 2022
·
2 min read
Business

NeoImmuneTech Welcomes New Members to its Scientific Advisory Board

NeoImmuneTech, Inc. (NIT or “NeoImmuneTech”), a clinical-stage T cell-focused biopharmaceutical company, today announces the appointment of new members of its Scientific Advisory Board.

August 8, 2022
·
5 min read
BioMidwest

Omaha-Based MRI Medical Device Company, Bot Image, Receives FDA Clearance for Artificial Intelligence Software Used in Detection and Diagnosis of Prostate Cancer

Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).

August 8, 2022
·
3 min read
Business

BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call - Aug 08, 2022

BioPorto A/S announced that in connection with the release of its Interim Report for the second quarter of 2022, the Company’s management team will host an online investor presentation on August 17, 2022 at 14:00 Central European Time / 8:00 Eastern Time via HC Andersen Capital.

August 8, 2022
·
2 min read